. 2022 Oct 29;11(21):6399. doi: 10.3390/jcm11216399

Table 5.

Correlations between mSEPT9 and the clinicopathologic characteristics of the GC group.

Clinicopathological Characteristics	SEPT9
Clinicopathological Characteristics	n	Positive (1/3)	Negative (1/3)	p (1/3)	Positive (2/3)	Negative (2/3)	p (2/3)	Mean Ct Value	p
Sex				0.185			0.099		0.107
Male	44	19	25		12	32		41.93
Female	16	10	6		8	8		38.36
Age (years)				0.821			0.461		0.408
<70	34	16	18		10	24		41.57
≥70	26	13	13		10	16		40.21
Tumor location				0.639			0.906
Upper third	16	8	8		5	11		NA
Middle third	20	12	8		7	13		NA
Lower third	18	7	11		6	12		NA
>2/3 stomach	4	2	2		2	2		NA
NA	2	0	2		0	2
Tumor size (cm)				0.494			0.450		0.296
<6.0	25	11	14		7	18		41.82
≥6.0	32	17	15		12	20		40.04
NA	3	1	2		1	2
T stage				0.041			0.047		0.179
Tis + T1 + T2 + T3	20	6	14		4	16		42.16
T4	34	20	14		16	18		39.70
NA	6	3	3		0	6
N stage				0.018			0.035		0.002
N0 + N1	23	7	16		5	18		43.39
N2 + N3	30	19	11		15	15		38.33
NA	7	3	4		0	7
M stage				0.019			0.008		0.002
M0	38	14	24		8	30		43.16
M1	22	15	7		12	10		37.21
NA	0	0	0		0	0
Clinical stage				0.019			0.294		0.001
0 + I + II	11	2	9		2	9		44.16
III + IV	45	26	19		18	27		39.88
NA	4	1	3		0	4
Differentiation				0.124			0.090		0.171
High + moderate	12	4	8		2	10		42.71
low	32	19	13		15	17		39.79
NA	16	6	10		3	13
Lauren type				0.727			0.459		0.466
Intestinal	10	4	6		2	8		42.26
Diffuse	38	19	19		15	23		40.65
NA	12	6	6		3	9